Cytokines and cytotoxic pathways in engraftment resistance to purified allogeneic hematopoietic stem cells

Biology of Blood and Marrow Transplantation

Volumn 11, Issue 1, 2005, Pages 1-12

  Scheffold, Christian ^a   Scheffold, Yolanda C ^a   Cao, Thai M ^a   Gworek, Jennifer ^a   Shizuru, Judith A ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cytokines; Engraftment; Fas ligand; Perforin; Stem cell transplantation

Indexed keywords

CD8 ANTIGEN; CYTOKINE; FAS LIGAND; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; LYMPHOCYTE ANTIBODY; PERFORIN; POLYCLONAL ANTIBODY; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CELL POPULATION; CHIMERA; CONTROLLED STUDY; DATA ANALYSIS; GRAFT REJECTION; HEMATOPOIESIS; IMMUNE RESPONSE; IMMUNOPATHOLOGY; IMMUNOREGULATION; KNOCKOUT MOUSE; LYMPHOCYTOTOXICITY; MOLECULAR MECHANICS; MOUSE; MOUSE STRAIN; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PURIFICATION; RECIPIENT; WILD TYPE;

ANIMALS; ANTIBODIES; ANTIGENS, CD8; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; FAS LIGAND PROTEIN; GRAFT REJECTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; PORE FORMING CYTOTOXIC PROTEINS; SURVIVAL RATE; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HOMOLOGOUS;

EID: 11244304191     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2004.10.002     Document Type: Article

References (63)

1. P.L. Weiden N. Flournoy E.D. Thomas et al. Antileukemic effect of graft-versus-host disease in human recipients of allogeneic-marrow grafts N Engl J Med. 300 1979 1068-1073
2. M.M. Horowitz R.P. Gale P.M. Sondel et al. Graft-versus-leukemia reactions after bone marrow transplantation Blood 75 1990 555-562
3. P.J. Martin G. Schoch L. Fisher et al. A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment Blood 76 1990 1464-1472
4. H. Goker I.C. Haznedaroglu N.J. Chao Acute graft-vs-host disease: pathobiology and management Exp Hematol. 29 2001 259-277
5. D. Maraninchi E. Gluckman D. Blaise et al. Impact of T-cell depletion on outcome of allogeneic bone-marrow transplantation for standard-risk leukaemias Lancet 2 1987 175-178
6. P.J. Martin J.A. Hansen B. Torok-Storb et al. Graft failure in patients receiving T cell-depleted HLA-identical allogeneic marrow transplants Bone Marrow Transplant. 3 1988 445-456
7. J.M. Goldman R.P. Gale M.M. Horowitz et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion Ann Intern Med. 108 1988 806-814
8. A.M. Marmont M.M. Horowitz R.P. Gale et al. T-cell depletion of HLA-identical transplants in leukemia Blood 78 1991 2120-2130
9. O. Ringden M. Remberger J. Aschan et al. Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients Transplantation 58 1994 887-891
10. R.E. Champlin M.M. Horowitz D.W. van Bekkum et al. Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results Blood 73 1989 606-613
11. S.M. Davies C. Kollman C. Anasetti et al. Engraftment and survival after unrelated-donor bone marrow transplantation: A report from the national marrow donor program Blood 96 2000 4096-4102
12. G. Cudkowicz M. Bennett Peculiar immunobiology of bone marrow allografts. I. Graft rejection by irradiated responder mice J Exp Med. 134 1971 83-102
13. R. Kiessling P.S. Hochman O. Haller et al. Evidence for a similar or common mechanism for natural killer cell activity and resistance to hemopoietic grafts Eur J Immunol. 7 1977 655-663
14. M. Bennett Biology and genetics of hybrid resistance Adv Immunol. 41 1987 333-445
15. G. Dennert C.G. Anderson J. Warner T killer cells play a role in allogeneic bone marrow graft rejection but not in hybrid resistance J Immunol. 135 1985 3729-3734
16. W.J. Murphy V. Kumar M. Bennett Acute rejection of murine bone marrow allografts by natural killer cells and T cells. Differences in kinetics and target antigens recognized J Exp Med. 166 1987 1499-1509
17. V. Kumar T. George Y.Y. Yu J. Liu M. Bennett Role of murine NK cells and their receptors in hybrid resistance Curr Opin Immunol. 9 1997 52-56
18. C.D. Heidecke J.L. Araujo J.W. Kupiec-Weglinski et al. Lack of evidence for an active role for natural killer cells in acute rejection of organ allografts Transplantation 40 1985 441-444
19. Y.Y. Yu V. Kumar M. Bennett Murine natural killer cells and marrow graft rejection Annu Rev Immunol. 10 1992 189-213
20. M. Waterfall L.S. Rayfield L. Brent The role of natural killer cells in resistance to allogeneic and parental hybrid resistance Transplantation 43 1987 312-314
21. L.A. Lee J.J. Sergio M. Sykes Natural killer cells weakly resist engraftment of allogeneic, long-term, multilineage-repopulating hematopoietic stem cells Transplantation 61 1996 125-132
22. M.G. Lichtenheld K.J. Olsen P. Lu et al. Structure and function of human perforin Nature 335 1988 448-451
23. G. Trinchieri Biology of natural killer cells Adv Immunol. 47 1989 187-376
24. M.P. Hayes G.A. Berrebi P.A. Henkart Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A J Exp Med. 170 1989 933-946
25. C.C. Liu P.M. Persechini J.D. Young Perforin and lymphocyte-mediated cytolysis Immunol Rev. 146 1995 145-175
26. D. Kagi B. Ledermann K. Burki R.M. Zinkernagel H. Hengartner Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo Annu Rev Immunol. 14 1996 207-232
27. E. Rouvier M.F. Luciani P. Golstein Fas involvement in Ca(2+)-independent T cell-mediated cytotoxicity J Exp Med. 177 1993 195-200
28. T. Suda T. Takahashi P. Golstein S. Nagata Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family Cell 75 1993 1169-1178
29. H. Arase N. Arase T. Saito Fas-mediated cytotoxicity by freshly isolated natural killer cells J Exp Med. 181 1995 1235-1238
30. A.H. Montel M.R. Bochan J.A. Hobbs D.H. Lynch Z. Brahmi Fas involvement in cytotoxicity mediated by human NK cells Cell Immunol. 166 1995 236-246
31. P.A. Henkart Mechanism of lymphocyte-mediated cytotoxicity Annu Rev Immunol. 3 1985 31-58
32. W.M. Yokoyama W.E. Seaman The Ly-49 and NKR-P1 gene families encoding lectin-like receptors on natural killer cells: The NK gene complex Annu Rev Immunol. 11 1993 613-635
33. C.N. Baxevanis I.F. Voutsas O.E. Tsitsilonis et al. Compromised anti-tumor responses in tumor necrosis factor-alpha knockout mice Eur J Immunol. 30 2000 1957-1966
34. L. Gorelik R.A. Flavell Transforming growth factor-beta in T-cell biology Nat Rev Immunol. 2 2002 46-53
35. H.L. Aguila I.L. Weissman Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells Blood 87 1996 1225-1231
36. M.B. Baker E.R. Podack R.B. Levy Perforin- and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice Biol Blood Marrow Transplant. 1 1995 69-73
37. T.A. Graubert J.H. Russell T.J. Ley The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection Blood 87 1996 1232-1237
38. M.A. Taylor B. Ward J.D. Schatzle M. Bennett Perforin- and Fas-dependent mechanisms of natural killer cell-mediated rejection of incompatible bone marrow cell grafts Eur J Immunol. 32 2002 793-799
39. M. Komatsu M. Mammolenti M. Jones et al. Antigen-primed CD8+ T cells can mediate resistance preventing allogeneic marrow engraftment in the simultaneous absence of perforin, CD95L, TNFR1 and TRAIL dependent killing Blood 101 2003 3991-3999
40. J.A. Shizuru L. Jerabek C.T. Edwards I.L. Weissman Transplantation of purified hematopoietic stem cells: Requirements for overcoming the barriers of allogeneic engraftment Biol Blood Marrow Transplant. 2 1996 3-14
41. G.J. Spangrude S. Heimfeld I.L. Weissman Purification and characterization of mouse hematopoietic stem cells Science 241 1988 58-62
42. G.F. Beilhack Y.C. Scheffold I.L. Weissman et al. Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice Diabetes 52 2003 59-68
43. L. Stitz J. Baenziger H. Pircher H. Hengartner R.M. Zinkernagel Effect of rabbit anti-asialo GM1 treatment in vivo or with anti-asialo GM1 plus complement in vitro on cytotoxic T cell activities J Immunol. 136 1986 4674-4680
44. S. Ehl R. Nuesch T. Tanaka et al. A comparison of efficacy and specificity of three NK depleting antibodies J Immunol Methods 199 1996 149-153
45. B. Yankelevich C. Knobloch M. Nowicki G. Dennert A novel cell type responsible for marrow graft rejection in mice. T cells with NK phenotype cause acute rejection of marrow grafts J Immunol. 142 1989 3423-3430
46. H.L. Aguila K. Akashi J. Domen et al. From stem cells to lymphocytes: biology and transplantation Immunol Rev. 157 1997 13-40
47. K.L. Gandy J. Domen H. Aguila I.L. Weissman CD8+TCR+ and CD8+TCR- cells in whole bone marrow facilitate the engraftment of hematopoietic stem cells across allogeneic barriers Immunity 11 1999 579-590
48. M. Kasai T. Yoneda S. Habu et al. In vivo effect of anti-asialo GM1 antibody on natural killer activity Nature 291 1981 334-335
49. K. Okumura S. Habu K. Shimamura The role of asialo GM1+ cells in the resistance of transplants of bone marrow or other tissues. In: R.B. Herberman (Ed.). NK Cells and Other Natural Effector Cells 1982 Academic Press New York 1566
50. E. Lotzova C.A. Savary S.B. Pollack Prevention of rejection of allogeneic bone marrow transplants by NK 1.1 antiserum Transplantation 35 1983 490-494
51. P. Tiberghien D.L. Longo J.W. Wine W.G. Alvord C.W. Reynolds Anti-asialo GM1 antiserum treatment of lethally irradiated recipients before bone marrow transplantation: Evidence that recipient natural killer depletion enhances survival, engraftment, and hematopoietic recovery Blood 76 1990 1419-1430
52. M. Bennett P.A. Taylor M. Austin et al. Cytokine and cytotoxic pathways of NK cell rejection of class I-deficient bone marrow grafts: Influence of mouse colony environment Int Immunol. 10 1998 785-790
53. W.J. Murphy J.R. Keller C.L. Harrison H.A. Young D.L. Longo Interleukin-2-activated natural killer cells can support hematopoiesis in vitro and promote marrow engraftment in vivo Blood 80 1992 670-677
54. T. Sato C. Selleri S. Anderson N.S. Young J.P. Maciejewski Expression and modulation of cellular receptors for interferon-gamma, tumour necrosis factor, and Fas on human bone marrow CD34+ cells Br J Haematol. 97 1997 356-365
55. D. Bryder V. Ramsfjell I. Dybedal et al. Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation J Exp Med. 194 2001 941-952
56. K. Takenaka K. Nagafuji M. Harada et al. In vitro expansion of hematopoietic progenitor cells induces functional expression of Fas antigen (CD95) Blood 88 1996 2871-2877
57. J. Maciejewski C. Selleri S. Anderson N.S. Young Fas antigen expression on CD34+ human marrow cells is induced by interferon gamma and tumor necrosis factor alpha and potentiates cytokine-mediated hematopoietic suppression in vitro Blood 85 1995 3183-3190
58. K. Nagafuji T. Shibuya M. Harada et al. Functional expression of Fas antigen (CD95) on hematopoietic progenitor cells Blood 86 1995 883-889
59. K.M. Verbanac F.M. Carver C.E. Haisch J.M. Thomas A role for transforming growth factor-beta in the veto mechanism in transplant tolerance Transplantation 57 1994 893-900
60. M. Bennett G. Cudkowicz R.S. Foster Jr D. Metcalf Hemopoietic progenitor cells of W anemic mice studies in vivo and in vitro J Cell Physiol. 71 1968 211-226
61. T. Na Nakorn D. Traver I.L. Weissman K. Akashi Myeloerythroid-restricted progenitors are sufficient to confer radioprotection and provide the majority of day 8 CFU-S J Clin Invest. 109 2002 1579-1585
62. P.J. Quesenberry F.M. Stewart P. Becker et al. Stem cell engraftment strategies Ann N Y Acad Sci. 938 2001 54-61
63. E. Bachar-Lustig N. Rachamim H.W. Li F. Lan Y. Reisner Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice Nat Med. 1 1995 1268-1273